<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d536">
    <sentence id="DDI-DrugBank.d536.s0" text="Certain drugs tend to produce hyperglycemia and may lead to loss of blood glucose control."/>
    <sentence id="DDI-DrugBank.d536.s1" text="These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid.">
        <entity id="DDI-DrugBank.d536.s1.e0" charOffset="24-32"
            type="group" text="thiazides"/>
        <entity id="DDI-DrugBank.d536.s1.e1" charOffset="44-52"
            type="group" text="diuretics"/>
        <entity id="DDI-DrugBank.d536.s1.e2" charOffset="55-69"
            type="group" text="corticosteroids"/>
        <entity id="DDI-DrugBank.d536.s1.e3" charOffset="72-85"
            type="group" text="phenothiazines"/>
        <entity id="DDI-DrugBank.d536.s1.e4" charOffset="88-103"
            type="group" text="thyroid products"/>
        <entity id="DDI-DrugBank.d536.s1.e5" charOffset="106-114"
            type="group" text="estrogens"/>
        <entity id="DDI-DrugBank.d536.s1.e6" charOffset="122-135"
            type="group" text="contraceptives"/>
        <entity id="DDI-DrugBank.d536.s1.e7" charOffset="138-146"
            type="drug" text="phenytoin"/>
        <entity id="DDI-DrugBank.d536.s1.e8" charOffset="149-162"
            type="drug" text="nicotinic acid"/>
        <entity id="DDI-DrugBank.d536.s1.e9" charOffset="165-180"
            type="group" text="sympathomimetics"/>
        <entity id="DDI-DrugBank.d536.s1.e10" charOffset="183-212"
            type="group" text="calcium channel-blocking drugs"/>
        <entity id="DDI-DrugBank.d536.s1.e11" charOffset="219-227"
            type="drug" text="isoniazid"/>
    </sentence>
    <sentence id="DDI-DrugBank.d536.s2" text="When such drugs are administered to a patient receiving Acarbose, the patient should be closely observed for loss of blood glucose control.">
        <entity id="DDI-DrugBank.d536.s2.e0" charOffset="56-63"
            type="drug" text="Acarbose"/>
    </sentence>
    <sentence id="DDI-DrugBank.d536.s3" text="When such drugs are withdrawn from patients receiving Acarbose in combination with sulfonylureas or insulin, patients should be observed closely for any evidence of hypoglycemia.">
        <entity id="DDI-DrugBank.d536.s3.e0" charOffset="54-61"
            type="drug" text="Acarbose"/>
        <entity id="DDI-DrugBank.d536.s3.e1" charOffset="83-95"
            type="group" text="sulfonylureas"/>
        <entity id="DDI-DrugBank.d536.s3.e2" charOffset="100-106"
            type="drug" text="insulin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d536.s4" text="Intestinal adsorbents (e. g., charcoal) and digestive enzyme preparations containing carbohydrate-splitting enzymes (e. g., amylase, pancreatin) may reduce the effect of Acarbose and should not be taken concomitantly.">
        <entity id="DDI-DrugBank.d536.s4.e0" charOffset="0-20"
            type="group" text="Intestinal adsorbents"/>
        <entity id="DDI-DrugBank.d536.s4.e1" charOffset="30-37"
            type="drug" text="charcoal"/>
        <entity id="DDI-DrugBank.d536.s4.e2" charOffset="44-72"
            type="group" text="digestive enzyme preparations"/>
        <entity id="DDI-DrugBank.d536.s4.e3" charOffset="124-130"
            type="drug" text="amylase"/>
        <entity id="DDI-DrugBank.d536.s4.e4" charOffset="133-142"
            type="drug" text="pancreatin"/>
        <entity id="DDI-DrugBank.d536.s4.e5" charOffset="170-177"
            type="drug" text="Acarbose"/>
        <ddi id="DDI-DrugBank.d536.s4.d0" e1="DDI-DrugBank.d536.s4.e0"
            e2="DDI-DrugBank.d536.s4.e5" type="mechanism"/>
        <ddi id="DDI-DrugBank.d536.s4.d1" e1="DDI-DrugBank.d536.s4.e1"
            e2="DDI-DrugBank.d536.s4.e5" type="mechanism"/>
        <ddi id="DDI-DrugBank.d536.s4.d2" e1="DDI-DrugBank.d536.s4.e3"
            e2="DDI-DrugBank.d536.s4.e5" type="mechanism"/>
        <ddi id="DDI-DrugBank.d536.s4.d3" e1="DDI-DrugBank.d536.s4.e4"
            e2="DDI-DrugBank.d536.s4.e5" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d536.s5" text="Acarbose has been shown to change the bioavailabillty digoxin when they are co-administered, which may require digoxin dose adjustment.">
        <entity id="DDI-DrugBank.d536.s5.e0" charOffset="0-7"
            type="drug" text="Acarbose"/>
        <entity id="DDI-DrugBank.d536.s5.e1" charOffset="54-60"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d536.s5.e2" charOffset="111-117"
            type="drug" text="digoxin"/>
        <ddi id="DDI-DrugBank.d536.s5.d0" e1="DDI-DrugBank.d536.s5.e0"
            e2="DDI-DrugBank.d536.s5.e1" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d536.s6" text="Studies in healthy volunteers have shown that Acarbose has no effect on either the pharmacokinetics or pharmacodynamics of digoxin, nifedipine, propranolol, or ranitidine.">
        <entity id="DDI-DrugBank.d536.s6.e0" charOffset="46-53"
            type="drug" text="Acarbose"/>
        <entity id="DDI-DrugBank.d536.s6.e1" charOffset="123-129"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d536.s6.e2" charOffset="132-141"
            type="drug" text="nifedipine"/>
        <entity id="DDI-DrugBank.d536.s6.e3" charOffset="144-154"
            type="drug" text="propranolol"/>
        <entity id="DDI-DrugBank.d536.s6.e4" charOffset="160-169"
            type="drug" text="ranitidine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d536.s7" text="Acarbose did not interfere with the absorption or disposition of the sulfonylurea glyburide in diabetic patients.">
        <entity id="DDI-DrugBank.d536.s7.e0" charOffset="0-7"
            type="drug" text="Acarbose"/>
        <entity id="DDI-DrugBank.d536.s7.e1" charOffset="69-80"
            type="drug" text="sulfonylurea"/>
        <entity id="DDI-DrugBank.d536.s7.e2" charOffset="82-90"
            type="drug" text="glyburide"/>
    </sentence>
    <sentence id="DDI-DrugBank.d536.s8" text="Acarbose may affect digoxin bioavailabillty and may require dose adjustment of digoxin by 16% (90% confidence interval: 8-23%), decrease mean C max digoxin by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of digoxin by 9% (90% confidence limit: 19% decrease to 2% increase).">
        <entity id="DDI-DrugBank.d536.s8.e0" charOffset="0-7"
            type="drug" text="Acarbose"/>
        <entity id="DDI-DrugBank.d536.s8.e1" charOffset="20-26"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d536.s8.e2" charOffset="79-85"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d536.s8.e3" charOffset="148-154"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d536.s8.e4" charOffset="240-246"
            type="drug" text="digoxin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d536.s9" text="The amount of metformin absorbed while taking Acarbose was bioequivalent to the amount absorbed when taking placebo, as indicated by the plasma AUC values.">
        <entity id="DDI-DrugBank.d536.s9.e0" charOffset="14-22"
            type="drug" text="metformin"/>
        <entity id="DDI-DrugBank.d536.s9.e1" charOffset="46-53"
            type="drug" text="Acarbose"/>
    </sentence>
    <sentence id="DDI-DrugBank.d536.s10" text="However, the peak plasma level of metformin was reduced by approximately 20% when taking Acarbose due to a slight delay in the absorption of metformin.">
        <entity id="DDI-DrugBank.d536.s10.e0" charOffset="34-42"
            type="drug" text="metformin"/>
        <entity id="DDI-DrugBank.d536.s10.e1" charOffset="89-96"
            type="drug" text="Acarbose"/>
        <entity id="DDI-DrugBank.d536.s10.e2" charOffset="141-149"
            type="drug" text="metformin"/>
        <ddi id="DDI-DrugBank.d536.s10.d0" e1="DDI-DrugBank.d536.s10.e0"
            e2="DDI-DrugBank.d536.s10.e1" type="mechanism"/>
        <ddi id="DDI-DrugBank.d536.s10.d1" e1="DDI-DrugBank.d536.s10.e1"
            e2="DDI-DrugBank.d536.s10.e2" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d536.s11" text="There is little if any clinically significant interaction between Acarbose and metformin.">
        <entity id="DDI-DrugBank.d536.s11.e0" charOffset="66-73"
            type="drug" text="Acarbose"/>
        <entity id="DDI-DrugBank.d536.s11.e1" charOffset="79-87"
            type="drug" text="metformin"/>
    </sentence>
</document>
